These success, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 guidance the principle of focusing on ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Conditions.Howdy. I just needed to Permit folks u